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Abstract
Background: The Gateway recombinatorial cloning system allows easy and rapid joining of DNA
fragments. Here we report the construction and evaluation of three different Gram-positive
vectors that can be used with the Multisite Gateway cloning system to rapidly produce new gene
arrangements in plasmid constructs for use in a variety of Gram-positive bacteria.
Results: Comparison of patterns of reporter gene expression with conventionally constructed
clones show that the presence of residual recombination (att) sites does not have an effect on
patterns of gene expression, although overall levels of gene expression may vary. Rapid
construction of these new vectors allowed vector/gene combinations to be optimized following
evaluation of plasmid constructs in different bacterial cells and demonstrates the benefits of plasmid
construction using Gateway cloning.
Conclusion:  The residual att  sites present after Gateway cloning did not affect patterns of
promoter induction in Gram-positive bacteria and there was no evidence of differences in mRNA
stability of transcripts. However overall levels of gene expression may be reduced, possibly due to
some post-transcriptional event. The new vectors described here allow faster, more efficient
cloning in range of Gram-positive bacteria.
Background
The study of gene expression in bacteria has advanced rap-
idly over the last two decades. In addition to traditional
mutagenesis approaches, the characterization of gene
function increasingly requires the investigation of DNA
segments containing promoters and their associated regu-
latory sequences. While many cloning and expression vec-
tors have been developed for use in Gram-negative
bacteria, there is a paucity of equivalent materials for use
when working in Gram-positive bacteria.
Recombinatorial cloning systems, such as Invitrogen's
'Gateway' provide an alternative to conventional cloning
that uses restriction enzymes and ligation. The Gateway
system uses directed recombination between modified
attachment (att) sites derived from E. coli bacteriophage λ.
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The  λ integration system mediates two recombination
reactions to promote either integration or excision of the
phage genome from the E. coli chromosome. During inte-
gration the phage attP site recombines with the related,
but non-identical, bacterial attB site producing hybrid attL
and attR sequences located to the left and right of the
phage genome, respectively. This recombination is medi-
ated by integrase (Int) and integration host factor (IHF).
To achieve excision of the phage from the chromosome
attLand attR are recombined to regenerate attB and attP in
a reaction mediated by Int in combination with the exci-
sionase (Xis) and IHF [see [1]]. For the Gateway system,
modified  att  recombination sites have been developed
with recombination specificity, such that the variant attB1
will recombine with attP1 but not with other attP variants.
Introducing these variant att sites at the ends of fragments
to be cloned allows them to be recombined with vectors
containing cognate attB sites, maintaining the orientation
of DNA fragments during the in vitro recombination [2-4].
To facilitate the recombinatorial cloning, the appropriate
enzymes are supplied by the manufacturer as BP clonase,
that mediates attB/attP  recombination events, and LR
clonase to mediate recombination between attL/attR
sequences.
The Multisite Gateway cloning technology is designed to
place three DNA fragments adjacent to each other in a spe-
cific order and orientation. The procedure is carried out in
two stages, the first of which is a BP reaction to transfer a
linear DNA fragment flanked by attB sites (generated by
PCR) into a plasmid, termed an Entry Vector, containing
cognate attP sites. This creates Entry Clones containing the
desired DNA fragment flanked by attR or attL sites. These
can be selected by loss of the counter-selectable marker
[ccdB; [5]] present in the original Entry Vector after trans-
formation into E. coli (see Fig. 1). To create three fragment
gene fusions, three such Entry Clones containing different
attL/attR variants are created and then utilised in a second
recombination step with a Destination Vector containing
appropriate attR sites and ccdB using LR clonase (Fig. 2).
Selection of correct Destination Clones is again facilitated
by counter selection of ccdB that should be lost from the
Destination Vector during the recombination event. The
major advantage of this system is its ease and efficiency
but residual att sites are left flanking DNA fragments (Fig.
3) and there has been some concern that these may affect
gene expression from the plasmid constructs created.
The Gateway system has been primarily developed for
Gram-negative bacteria or eukaryotic systems. Recently
Bae and Schneewind [6] have described the development
of simple Gateway vectors for use in Gram-positive bacte-
ria, where only one fragment at a time is recombined into
a Destination vector. We present here the construction of
Multisite Gateway Destination Vectors based upon 3 dif-
ferent Gram-positive plasmid replicons that will allow the
use of this rapid cloning technique in a wide range of
Gram-positive bacterial hosts. These were used to con-
struct reporter gene plasmids with the general structure
Promoter:Reporter:Terminator which were then used to
introduce both lux and gfp reporter genes into Staphylo-
coccus aureus, Listeria monocytogenes and Bacillus subti-
lis. To determine whether the residual att sites have any
effect on gene expression, reporter gene expression from a
Promoter:Reporter:Terminator cassette constructed using
either Gateway or conventional cloning methods were
compared.
Construction of Entry Clones using the BP reaction Figure 1
Construction of Entry Clones using the BP reaction. 
The BP recombination transfers a DNA fragment flanked by 
attB sites (white boxes) into a plasmid containing cognate attP 
sites (black boxes), termed an Entry Vector. The resultant 
Entry Clone contains the desired DNA fragment flanked by 
attR or attL sites (grey boxes), depending on the orientation 
of the attB and attP sites.
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Results
Constructing a Gram-positive destination vector
A prerequisite for the Multisite Gateway system is a Desti-
nation vector containing a CmR-ccdB cassette flanked by
attR4 and attR3 sites. This was amplified from pDESTR4-
R3 (Invitrogen) using primers PmeattR3 and PmeattR4
(Table 1) to generate a 1770 bp PCR product. This ampli-
con was cut with PmeI and ligated into the Gram-positive
shuttle vectors pMK4 (SmaI site), pHB201 (PvuII/PmeI
sites) and pUNK1 (SmaI site). These recombinant plas-
mids were used to transform E. coli DB3.1 (gyrA) that can
tolerate the ccdB gene. Resulting plasmids were character-
ised by restriction mapping and sequence analysis. These
new Gram-positive destination vectors were given the des-
ignation pDEST-pMK4, pDEST-pHB201 and pDEST-
pUNK1, respectively.
Entry clone construction
A number of Entry Clones using the Entry Vectors from
the Gateway construction kit were then prepared to allow
us to rapidly create reporter plasmids for use in Gram-pos-
itive bacteria. In each case the required sequence was
amplified by PCR using the primers listed in Table 1 and
introduced into the entry vectors using the BP recombina-
tion reaction (see Fig. 2) and each of the resulting Entry
Clones was characterised by restriction mapping and
sequence analysis. First a 3' Entry Clone was created using
plasmid pDONOR-P2R-P3 containing the transcriptional
terminator (rrnBT1T2) amplified from pTRC99A as E. coli
terminators have been previously demonstrated to func-
tion in Gram-positive bacteria [7]. Secondly a series of
reporter gene entry clones were created using pDONOR-
221. These contained either the gfp or luxABCDE, or both
reporter systems (gfp:luxABCDE) [8-10]. Finally a series of
5' entry clones were created using plasmid pDONOR-P4-
P1R. The promoter fragments chosen were those that we
have previously used to create reporter gene constructs in
Gram positive bacteria and included xylose utilisation
gene (PxylA [11]) amplified from B. megaterium chromo-
somal DNA and the small acid soluble protein (SASP)
gene promoter (PsspA: [12]) amplified from B. subtilis chro-
mosomal DNA. In addition PxylA was also amplified from
B. megaterium along with its cognate regulator protein
XylR (XylR PxylA [11]).
Construction of reporter plasmids using Gateway 
recombination
After generating the Entry Clones containing the promot-
ers, reporter genes and transcriptional terminator, the
MultiSite Gateway LR reaction was performed with the
new Gram-positive destination vectors to create expres-
sion clones with the following structure, attB4-promoter-
attB1-reporter gene-attB2-terminator-attB3  (see Fig. 2).
Each LR reaction mixture was transformed into E. coli
Top10 competent cells to select for loss of the ccdB gene.
Transformants were then screened for the expression of
the appropriate reporter genes and in each case the struc-
ture of clones was confirmed by restriction and sequence
analysis. All final expression constructs created using this
Gateway system contain 4 attB sites (see Fig. 2).
Construction of expression clones for Staphylococcus 
aureus
Previously we have successfully used reporter gene con-
structs based on the shuttle vector pMK4 for studies in
Gram-positive bacteria [8-10], therefore pDEST-pMK4
was chosen as the first destination vector to be evaluated.
Constructs were created containing xylR  PxylA  fused to
either the gfp or luxABCDE followed by the terminator
sequence (pSB3004 and pSB3014, respectively; see Fig. 3
and Table 2) and these were transformed into S. aureus
RN4220.
To investigate whether the presence of the attB  sites
between the various elements of the expression cassettes
affected patterns of gene expression, a series of parallel
constructs in pMK4 were created by conventional cloning.
To remove the att sites flanking the promoter in pSB3004,
the promoter and gfp reporter gene were replaced with an
equivalent fragment from pSB2018 [8] that contains no
Construction of Multisite Expression Clones using LR reac- tion Figure 2
Construction of Multisite Expression Clones using LR 
reaction. Three Entry Clones with the DNA fragments of 
interest flanked by attL4 and attR1 (Promoter), attL1 and 
attL2 (Reporter gene), and attR2 and attL3 (transcriptional 
terminator) recombine with a Destination Vector containing 
attR4 and attR3. During the LR reaction attL sites react only 
with their cognate attR sites resulting in a Destination Clone 
containing all three fragments fused together into the desired 
expression cassette. Expression Clone constructs are 
selected on the basis of the antibiotic resistance gene in the 
Destination vector. The by-product of this reaction is non-
replicative and its loss from the cell is further ensured by the 
presence of the ccdB counter-selectable marker gene.
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att sites (see methods section for details of plasmid con-
struction). Similarly to remove the attB sites flanking the
promoter in the luxABCDE expression vector pSB3014,
the 'bla xylR PxylAluxAB  fragment was replaced with an
equivalent fragment from pSB2026 [9] which again con-
tains no attB sites. The resulting gfp and lux constructs
were designated pSB3002 and pSB3012, respectively.
These constructs have two attB sites remaining, namely
attB2 and attB3 flanking the terminator (Fig. 3).
To construct a plasmid with an equivalent structure to
pSB3004 but without any attB sites, a terminator sequence
was inserted into plasmid pSB2018 in a PstI site located
immediately downstream of the PxylAgfp  sequence. The
resulting plasmid was designated pSB3000 and is equiva-
lent to pSB3002 but contains no attB sites flanking the ter-
minator (Fig. 3). To create the equivalent luxABCDE
reporter plasmid with no attB  sites, the gfp  gene was
excised from pSB2018 and a luxABCDE fragment inserted
in its place. The resulting plasmid was digested with PstI
and the rrnBT1T2 fragment cloned downstream of the lux
operon. This clone was designated pSB3010 (Fig. 3) and
sequencing analysis was used to confirm the presence of
the transcriptional terminator, promoter and reporter
genes in all new reporter constructs and successful dele-
tion of attB sites.
These experiments created pMK4-based plasmids where
no attB sites were present (pSB3000 and pSB3010) or with
only two attB  sites flanking the terminator sequence
(pSB3002 and pSB3012) or where 4 attB  sites were
present (pSB3004 and pSB3014) (see Table 2 and Fig. 3).
All of these plasmids contained the reporter genes under
the control of the xylose inducible promoter, PxylA, and
were transformed into S. aureus RN4420.
Evaluation of expression clones in Staphylococcus aureus
First the growth and expression of the PxylA lux expression
plasmids (pSB3010 [no attB sites], pSB3012 [[2]attB sites]
and pSB3014 [[4]attB sites]) were compared in rich broth
when the promoter systems were fully induced by addi-
tion of xylose throughout growth (Fig. 4). No significant
differences were seen in the growth of bacteria harboring
analogous plasmids and, as previously reported [9],
expression of the lux operon from this promoter was seen
to reach a maximum during the logarithmic growth
phase. Bioluminescence from expression plasmids
pSB3010 and pSB3012 was approximately equivalent
however light emission from pSB3014, which has two
additional attB sites flanking the promoter region, consist-
ently showed a lower light level, with typically half the
bioluminescence intensity of the other two plasmid con-
structs tested. Similar differences in light level from the 4
att constructs were also noted when lux expression from
the plasmids in L. monocytogenes was compared (data not
shown).
To try to elucidate whether the lower bioluminescence
observed when the promoter was flanked by attB sites was
due to differences in the rate of transcription or transla-
tion, a second series of experiments were carried out in
Effect of att sites on reporter gene expression in S. aureus Figure 4
Effect of att sites on reporter gene expression in S. 
aureus. S. aureus RN4220 with lux expression plasmids 
pSB3010 (❍ , ● ; 0 att sites), 2 pSB3012 (, ▲  2 att sites) or 
pSB3014 (, ■ ; 4 att sites) were grown in LB medium con-
taining 0.5% (w/v) xylose at 37°C. Growth (OD 600 nm; 
open symbols) and luminescence (Relative Light Units; RLU 
closed symbols) were monitored over time. Reporter gene 
data are presented as RLU/OD600 nm to account for increas-
ing cell number during the experiment.
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Structure of Expression Cassettes Figure 3
Structure of Expression Cassettes. Schematic of the dif-
ferent xylose-controllable expression cassettes created in 
pMK4, showing the plasmid name, corresponding reporter 
gene present and location of att sites for each construct.
attB4 xylR PxylA attB1 Reporter attB2 rrnBT1T2 attB3
xylR PxylA Reporter attB2 rrnBT1T2 attB3
xylR PxylA Reporter rrnBT1T2
No att sites: Plasmids pSB3000 (GFP) and pSB3010 (luxABCDE)
2 att sites: Plasmids pSB3002 (GFP) and pSB3012 (luxABCDE)
4 att sites: Plasmids pSB3004 (GFP) and pSB3014 (luxABCDE)BMC Molecular Biology 2007, 8:80 http://www.biomedcentral.com/1471-2199/8/80
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minimal media where the reporter gene expression was
only induced by addition of 0.5% (w/v) xylose once bac-
teria had entered the exponential phase of growth, and the
rate of gene induction was then followed. Both lux
(pSB3010, pSB3012 and pSB3014) and gfp (pSB3000 [no
Table 1: Primers for PCR and sequencing
Gateway primers Sequence (5-3') Use
Term attB2F GGGGACAGCTTTCTTG
TACAAAGTGGAAATCA
GAACGCAGAAGCGGT
C
Amplification of 
terminator
Term attB3R GGGGACAACTTTGTAT
AATAAGTTGTTTAAAC
TGGCAGTTTATGGCGG
GC
Amplification of 
terminator
Lux E attB2R GGGGACCACTTTGTAC
AAGAAAGCTGGGTTCA
ACTATCAAACGCTTCG
G
Amplification of lux 
reporter
GFP attB2R GGGGACCACTTTGTAC
AAGAAAGCTGGGTGAC
ACATTTATTTGTATAGT
TC
Amplification of gfp 
reporter
GFPopt attB1F GGGGACAAGTTTGTAC
AAAAAAGCAGGCTAGG
AGGAATAAAAAATGAG
TAAAGGCGAAGAAC
Amplification of gfp 
reporter
XylRA attB4F GGGGACAACTTTGTAT
AGAAAAGTTGCGTTGA
CTTAACTAACTTATAG
Amplification of xylR 
PxylA
XylRA attB1R GGGGACTGCTTTTTTG
TACAAACTTGTTGA 
TTTAAGTGAACAAGTT
TATC
Amplification of xylR 
PxylA
XylA attB4F GGGGACAACTTTGTAT
AGAAAAGTTGAAACAT
TGAAATAAACATTTATT
TTGTATATGATG
Amplification of PxylA
XylA attB1R GGGGACTGCTTTTTTG
TACAAACTTGTTGATTT
AAGTGAACAAGTTTAT
C
Amplification of PxylA
LuxA attB1F GGGGACAAGTTTGTAC
AAAAAAGCAGGCTAGG
AGGACTCTCTATGAAA
TTTGGAAAC
Amplification of lux 
reporter
SASP attB4F GGG GAC AAC TTT 
GTA TAG AAA AGT TGT 
TTA AAC GCT GGA 
ACC TTT TGT TCC CAA 
AAG
Amplification of 
PsspA
SASP attB1R GGG GAC TGC TTT TTT 
GTA CAA ACT TGT TTT 
ATT TAG TAT GGT TGG 
GTT AAC TGG
Amplification of 
PsspA
attR3 GGGGCGTTTAAACAAG
CTTGTAAAACGACGGC
CAGTG
sequencing
PMEattR4 GGGTTTAAACAACTTT
GTATAGAAAAGTTGAA
CGAG
sequencing
Ccdb Rev AGGAAGGGATGGCTG
AGGTC
sequencing
Cm R4-R3F CAGGCGGGCAAGAAT
GTGA
sequencing
Reporter gene induction kinetics Figure 5
Reporter gene induction kinetics. S. aureus RN4220 
containing reporter plasmids pSB3004 (, ■ ; 4 att sites), 
pSB3002 (, ▲ ; 2 att sites) and pSB3000 (❍ , ● ; no att sites) 
were grown to mid-log phase in Tris Minimal Succinate 
medium with 5 µg ml-1 Cm and then diluted 1/20 into fresh 
medium supplemented with 0.5% xylose. Triplicate samples 
were placed in a 96 well microtitre plate and incubated at 
37°C in a Tecan Genios Pro. Panel A: fluorescence (solid 
symbols, Relative Fluorescence Units; RFU) and absorbance 
(open symbols) were measured at 10 min intervals. Plasmids 
used were pSB3004 (, ■ ; 4 att sites), pSB3002 (, ▲ ; 2 att 
sites) and pSB3000 (❍ , ● ; no att sites). Panel B. luminescence 
(solid symbols, Relative Light Units; RLU)) and absorbance 
(open symbols) were measured at 10 min intervals. Plasmids 
used were pSB3014 (, ■ ; 4 att sites), pSB3012 (, ▲ ; 2 att 
sites) and pSB3010 (❍ , ● ; no att sites). Data is presented as 
% maximal signal to allow direct comparison of expression 
kinetics despite the fact that light levels from each construct 
were different.
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attB sites], pSB3002 [[2]attB sites] and pSB3004 [[4]attB
sites]) expression plasmids were used for these experi-
ments (Fig. 5). The induction of PxylA  led to a rapid
increase in fluorescence (Fig. 5a) and luminescence (Fig.
5b) for all reporter constructs. Sequences adjacent to
ribosome binding sites have previously been shown to
affect translational efficiency [13]. In our study no signif-
icant differences were found in the maximum rates of
induction of reporter activity when analogous plasmids
were compared. This indicates that neither the initiation
of transcription nor translation were affected by attB sites
proximal to the promoter or RBS of the reporter genes.
To ascertain if the presence of attB sites had any effect on
mRNA stability, repression of reporter gene transcription
was monitored following removal of xylose from xylose-
induced cultures. As shown in Figures 6a and 6b, removal
of xylose from logarithmically growing cells containing
the reporter plasmids resulted in an immediate reduction
of signal from both gfp and lux expression plasmids. A
faster decrease in signal was seen in bacteria harbouring
the lux constructs compared to the equivalent gfp con-
structs, as would be expected due to the longer half-life of
the GFP reporter molecule [9]. However the rate of loss of
signal was the same for all constructs indicating that the
presence of attB sites within the reporter gene structure did
not significantly alter the t1/2 of the mRNA.
Evaluation of expression clones in Listeria 
monocytogenes
Plasmid pMK4 is also known to replicate in L. monocy-
togenes [8] and in this case a dual reporter plasmid con-
taining both gfp  and the Gram-positive optimised lux
operon was created for evaluation in L. monocytogenes.
Plasmid pSB3005 contained the PxylA promoter fused to
the gfp:luxABCDE dual reporter operon and the rrnBT1T2
transcriptional terminator in pDEST-pMK4. When L.
monocytogenes NCTC 7973 cells containing pSB3005 were
grown in the presence of selective antibiotics, cultures
showed an extended lag phase but eventually grew at nor-
mal rates and achieved a cell density expected for L. mono-
cytogenes  cultures (see Fig. 7). When L.
monocytogenes(pSB3005) cells were visualised by fluores-
cence microscopy after overnight growth with antibiotic
selection, only approx. 20% of the cells expressed GFP,
suggesting either a high rate of selection of non-expressing
clones or plasmid instability.
While pMK4 has been found to be stable in S. aureus
[9,10], some plasmid instability had been observed in L.
monocytogenes (Hill, unpublished data) therefore plasmid
stability experiments were performed. To rule out any
effect on plasmid stability caused by expression of the
dual reporter gene operon, L. monocytogenes 7973(pMK4)
cells were also examined. After overnight culture (15 gen-
Reporter gene repression kinetics Figure 6
Reporter gene repression kinetics. S. aureus RN4220 
containing reporter plasmids pSB3004 (, ■ ; 4 att sites), 
pSB3002 (, ▲ ; 2 att sites) and pSB3000 (❍ , ● ; no att sites) 
were grown to mid-log phase in Tris Minimal Succinate 
medium with 5 µg ml-1 Cm and 0.5% xylose. Bacteria were 
washed and resuspended in an equal volume of medium con-
taining 5 µg ml-1 Cm and 1% glucose. Aliquots were placed in 
a 96 well microtitre plate and incubated at 37°C in a Tecan 
Genios Pro. Panel A: fluorescence (solid symbols, (Relative 
Fluorescence Units; RFU) and absorbance (open symbols) 
were measured at 10 min intervals. Plasmids used were 
pSB3004 (, ■ ; 4 att sites), pSB3002 (, ▲ ; 2 att sites) and 
pSB3000 (❍ , ● ; no att sites). Panel B: luminescence (solid 
symbols, Relative Light Units; RLU) and absorbance (open 
symbols) were measured at 10 minute intervals. Plasmids 
used were pSB3014 (, ■ ; 4 att sites), pSB3012 (, ▲ ; 2 att 
sites) and pSB3010 (❍ , ● ; no att sites). Data is presented as 
% maximal signal to allow direct comparison of repression 
kinetics despite the fact that light levels from each construct 
were different.
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erations) without antibiotic the average percentage loss of
pMK4 plasmids was 95% demonstrating that the plas-
mids were not stably maintained in L. monocytogenes with-
out selection. Individual values for plasmid loss with or
without the reporter gene were 94% (pMK4) or 97%
(pSB3005), respectively, and these values were not signif-
icantly different (P = 0.05). Therefore instability could not
be attributed to expression of the dual reporter gene
operon. When bacteria were grown in the presence of Cm
(7 µgml-1) selection, average plasmid loss for both plas-
mids was still high but decreased to 73%. This was a sur-
prising result since the presence of the antibiotic was
expected to completely stabilise the plasmid. Again no sig-
nificant difference in values for reporter plasmid and par-
ent vector were found.
To address this problem, a new reporter gene construct
(pSB3007) was created in the vector pDEST-pUNK1 [14]
containing PxylA:gfp:luxABCDE:rrnBT1T2. Both pSB3007
and pUNK1 were transformed into L. monocytogenes 7973
and plasmid stability experiments carried out. Average
plasmid loss of pUNK1 plasmids from cells grown in the
absence of antibiotic was only 25% (pUNK1) and 12%
(pSB3007). For bacteria grown in the presence of Erm (5
µgml-1) average plasmid loss did not improve and was
similar for pUNK1 and pSB3007 at approx. 22%. This
demonstrated that the pUNK1 plasmids are intrinsically
more stable in L. monocytogenes cells than the pMK4-based
constructs and shows that expression of the reporter genes
does not lead to higher levels of plasmid loss. Little addi-
tional plasmid stability was achieved for the pUNK1 plas-
mids when antibiotic selection was applied, showing that
these plasmids are appropriate to use in circumstances
where antibiotics cannot be used for plasmid selection.
To investigate whether the expression of the dual reporter
operon was stable, microscopic examination of bacteria
containing pSB3007 grown in the presence of Erm was
carried out. Very few cells were non-fluorescent, confirm-
ing that the majority of plasmid-containing cells also
expressed the reporter genes. Expression of the lux genes
was evaluated during growth of L. monocy-
togenes(pSB3007) in BHI broth in the presence of Erm. In
this case the extended lag phase identified when growing
the pMK4-based plasmid did not occur (see Fig. 7). Biolu-
minescence levels increased as cells entered the exponen-
tial phase of growth and began to decline in early
stationary phase (Fig. 7), following the pattern of expres-
sion previously reported for this promoter in L. monocy-
togenes [8]. This again confirmed that the presence of the
att sites in these constructs does not change the pattern of
expression of the reporter gene.
Evaluation of sspA expression clones in Bacillus subtilis
The differences in pMK4 plasmid stability seen in differ-
ent hosts demonstrated the importance of vector choice
when working in different Gram-positive bacteria. There-
fore to develop a Gateway Destination vector for Bacilli, a
plasmid containing the pTA1060 replicon known to be
stable through sporulation in B. subtilis was chosen
(pHB201; [12,15]). The Destination vector pDEST-
pHB201 was used to create an Expression Clone contain-
ing the promoter from the sporulation-associated SASP
gene (PsspA)fused to the dual reporter operon gfp:luxAB-
CDE (pSB3024; see Table 2). SASP is synthesised only
during sporulation to protect DNA within the spore [16].
The plasmid was transformed into the pyrB B. subtilis
strain, BGSC 1A393, that does not grow in minimal media
without added uracil. Cells were grown in rich broth and
then transferred into a sporulation minimal media
(SMM) without uracil supplement to encourage initiation
of sporulation due to nutrient limitation [17]. As
expected, no growth occurred in the SMM media, but a
strong induction of reporter gene expression was seen
after 3 h (Fig. 8). Light levels reach a maximum of 3000
RLU after 10 h and then began to decline. This peak of
gene expression suggests that a large number of the cells
in the population began sporulating at the same time, and
Comparison of vectors in L. monocytogenes Figure 7
Comparison of vectors in L. monocytogenes. L. monocy-
togenes 7973 plasmids based on the shuttle vector pMK4 (, 
▲ ; pSB3005) or pUNK1 ( ■ ; pSB3007) containing the 
gfp:luxABCDE operon under the control of the PxylApromoter 
(see Table 2). Cells were grown in MWB at 37°C and lumi-
nescence (closed symbols, Relative Light Units; RLU)) and 
growth measurements (open symbols) were taken at inter-
vals. Reporter gene data are presented as RLU/OD600 nm to 
account for increasing cell number during the experiment.
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corresponds with the expected σG-dependent expression
of PsspA in the developing forespore after sporulation initi-
ation in B. subtilis [18].
Discussion
The work presented here underlines the flexibility of the
MultiSite Gateway Technology to assemble multiple DNA
fragments precisely, efficiently, and directionally in a
defined order and orientation, without subcloning,
thereby negating the need for restriction enzymes and
DNA ligases. One concern raised about this cloning sys-
tem is the presence of the residual attB sites in the final
Expression Clone constructs. Here we show that no signif-
icant differences are seen in rates of gene induction due to
the presence of att sites within the expression cassettes,
although in this model system the amount of resultant
protein seems to be lower where attB sites are introduced
proximal to the promoter and RBS. Comparison of GFP
and Lux data indicated that mRNA half-life stability was
not affected by differences in mRNA structure between the
conventional and Gateway clones in S. aureus.
Another concern often expressed when using reporter
genes for in vivo studies is that the expression of the
reporter will place a metabolic burden on the bacteria and
therefore alter growth behaviour. In this case we have used
a dual reporter gene operon that encodes 6 genes in total
and yet there was no evidence of even high level expres-
sion affecting bacterial growth. However it is clear that
problems of vector maintenance may be of more signifi-
cance than any metabolic burden of the reporter genes. In
addition it is clear that antibiotic selection alone is not
sufficient to ensure that all cells in a population retain
reporter gene constructs, and that the choice of antibiotic
marker gene is also an important factor when designing
vectors. The high level of plasmid loss seen with pMK4
and its derivatives in the presence of Cm may be due to
the fact that the cat gene confers resistance by inactivation
of the antibiotic [19]. Hence during culture, levels of chlo-
ramphenicol in the media decrease and allow outgrowth
of plasmid-free segregants which no longer possess the
plasmid-borne cat. This may explain the long lag seen in
the growth experiments where antibiotics were added to
the growth media (see Fig. 7). In contrast the ermAM gene
present on pUNK1 confers resistance by methylation of
the rRNA [20] and therefore the antibiotic concentrations
will not decline and maintain selection throughout the
experiment. The lack of extended lag phase seen with
pUNK1-based vectors supports this hypothesis. This
makes the development of the Gateway cloning system
even more attractive for Gram-positive bacteria, as it is rel-
atively simple to generate new constructs in different vec-
tor when such effects are detected.
In this report we have used the Gateway system to rapidly
generate Expression Clone plasmids, however the same
Multisite DNA fragment fusion system could also be used
in site directed mutagenesis strategies by amplifying
upstream and downstream regions of a target gene and
recombining these with a marker gene that will replace the
target gene following in vivo recombination. Evaluation of
Gram-positive suicide Destination vectors is currently
underway and will facilitate mutational analysis of genes
in Gram-positive bacteria.
Conclusion
The residual attB sites resulting from Gateway cloning do
not affect gene expression in Gram-positive bacteria any
more than residual restriction sites resulting from conven-
tional cloning. The rapidity and precision of recombina-
torial cloning makes it the method of choice where precise
juxtaposition cloning of DNA sequences is not required,
and simplifies the construction of expression plasmids,
where multiple ligation steps are usually needed. A range
of vector systems with different origins of replication are
needed when working with diverse Gram-positive cell
types to ensure that data obtained is as robust as possible.
Methods
Bacterial strains and growth conditions
E. coli TOP10 (F-) and E. coli DB3.1 (F- gyrA462) were cul-
tivated in Luria-Bertani (LB; 5 g-1) broth or agar supple-
Pattern of PsspA promoter induction in Bacillus Figure 8
Pattern of PsspA promoter induction in Bacillus. B. subti-
lis(pSB3024) containing the Gram-positive optimised dual 
gfp:luxABCDE operon under the control of PsspA (see Table 2) 
was grown overnight in LB supplemented with 5 µg ml-1 Erm 
at 37°C. Cells were then harvested by centrifugation and 
washed with PBS before diluting 1/50 into SMM supple-
mented with 5 µg ml-1 Erm. Cultures were then incubated at 
37°C and luminescence (▲ , Relative Light Units; RLU)) and 
absorbance measurements (■ ) were taken at intervals.
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mented with appropriate antibiotics. L. monocytogenes
NCTC 7973 (ATCC NO. serovar 1/2a) was grown in
brain-heart infusion medium (BHI, Oxoid) or in the
chemically defined medium Modified Welshimer's Broth
(MWB; [21]). Bacillus subtilis BGSC 1A393 pyrB [22] was
cultivated in LB broth or in Spizizens Minimal Media
(SMM; 16). S. aureus RN4220 was grown in LB medium or
in Tris Minimal Succinate medium (TMS; [23]). Antibiot-
ics Ampicillin (Ap) Erythromycin (Erm) and Chloram-
phenicol (Cm) were used to select for plasmid
maintenance when appropriate. Long term stocks of bac-
terial strains were stored at -80°C in Microbank™ porous
beads.
Amplification of DNA
PCR reactions contained 10 µM of each primer, template
DNA at 0.2 ng µl-1 and 2.5 u of AccuPrime Taq  DNA
Polymerase High Fidelity (Invitrogen) according to the
Manufacturer's instructions. Bacillus megaterium NCTC
10342 DNA was used as template DNA for amplification
of the xylR PxylA fragment, B. subtilis 168 was used as tem-
plate for amplification of PsspA and plasmid pTMP100 was
used as template for amplification of reporter genes; this
plasmid contains the dual reporter genes gfp and luxAB-
CDE under the control of the S. aureus PrpsJ; all genes in the
lux operon are modified to achieve enhanced translation
in Gram-positive bacteria. PCR reactions were incubated
at 94°C for 1 min, followed by 30 cycles of 94°C for 30
sec, 52°C for 30 sec, and 68°C for 3 min (or 7 min for 6
kb fragments), with a final extension period at 68°C for
10 min. If non-specific PCR products were formed, anneal
temperatures were increased to a maximum of 60°C.
DNA manipulation & vector construction
Plasmids were prepared using Qiagen DNA purification
kits. Restriction enzyme analyses were performed using
standard procedures [24]. T4 DNA ligase (Promega) was
used for ligation of DNA fragments. PCR products and
restriction fragments were purified from low melting
point agarose gels using a Promega Wizard PCR purifica-
tion Kit and DNA fragments eluted in water. For Gateway
cloning, the Multisite Gateway Three-Fragment Vector
Construction kits were used according to manufactures
instructions (Invitrogen).
To create pSB3002 (2 att sites), pSB3004 was cut with
ScaI/MscI to release a fragment containing 'bla xylR PxylA
gfp'. This was replaced with a ScaI/MscI fragment from
pSB2018 (Table 2) containing the same promoter/
reporter gene sequences created by conventional cloning
and contains no att sites [8]. To create pSB3012 (2 att
sites), pSB3014 was restricted with ScaI/MluI to excise the
Table 2: Plasmids used in study
Plasmid Features of plasmid Reference/source
pTMP100 pMK4 containing S. aureus PrpsJ:gfp:luxABCDE Hill laboratory collection
pTRC99A rrnB T1, rrnB T2 27
pDONRP4-P1R Entry vector to clone attB4 and attB1 flanked PCR products, Kmr, Cmr, ccdB+ Invitrogen
pDONR221 Entry vector to clone attB1 and attB2 flanked PCR products, Kmr, Cmr, ccdB+ Invitrogen
pDONR P2R-P3 Entry vector to clone attB2 and attB3 flanked PCR products, Kmr, Cmr, ccdB+ Invitrogen
pDESTR4-R3 Destination vector, contains attR4/R3 sites. Recombines with entry clones in a Multisite 
Gateway LR reaction, Apr, Cmr, ccdB+
Invitrogen
pHB201 B. subtilis ori-pBR322, ori-1060, cat86:lacZα Cmr Emr 15
pMK4 Gram-Positive Shuttle vector, ApR, Cmr 28
pSB2018 pMK4 containing xylR PxylA:gfp 8
pSB2026 pMK4 containing xylR PxylA:luxABCDE Hill laboratory collection
pUNK1 Gram-positive shuttle vector, Emr 14
pDEST-pMK4 pMK4 containing attR4 and attR3 sites for recombination with entry clones in an LR reaction. 
Apr, Cmr, ccdB+
This work
pDEST-pUNK1 pUNK1 containing attR4 and attR3 sites for recombination with entry clones in an LR reaction. 
Emr, Cmr, ccdB+
This work
pDEST-pHB201 pHB201 containing attR4 and attR3 sites for recombination with entry clones in an LR reaction. 
Emr, Cmr, ccdB+
This work
pSB3000 3 fragment expression cassette in pMK4. xylR PxylA:gfp:rrnBT1T2 (0 attB) This work
pSB3002 3 fragment expression cassette in pMK4. xylR PxylA:gfp:rrnBT1T2 (2 attB) This work
pSB3004 3 fragment expression cassette in pMK4. xylR PxylA:gfp:rrnBT1T2 (4 attB) This work
pSB3005 3 fragment expression cassette in MK4. PxylA:gfp:luxABCDE rrnBT1T2 (4 attB) This work
pSB3007 3 fragment expression cassette in pUNK1. PxylA:gfp:luxABCDE:rrnBT1T2 (4 attB) This work
pSB3010 3 fragment expression cassette in pMK4. xylR PxylA:luxABCDE:rrnBT1T2 (0 attB) This work
pSB3012 3 fragment expression cassette in pMK4. xylR PxylA:luxABCDE:rrnBT1T2 (2 attB) This work
pSB3014 3 fragment expression cassette in pMK4. xylR PxylA:luxABCDE:rrnBT1T2 (4 attB) This work
pSB3024 3 fragment expression cassette in pHB201. PsspAgfp:luxABCDE:rrnBT1T2 (4 attB) This workBMC Molecular Biology 2007, 8:80 http://www.biomedcentral.com/1471-2199/8/80
Page 10 of 11
(page number not for citation purposes)
'bla xylR PxylA luxAB fragment and replaced with a ScaI/
MluI from pSB2026 [9] containing the same sequences
but without attB sites (see Fig. 3). Plasmid pSB3000 (no
att sites) was constructed by insertion of the rrnBT1T2
sequence amplified from pTRC99A, using primers incor-
porating 5' PstI and 3' NsiI sites, into plasmid pSB2018 in
the  PstI site immediately downstream of PxylAgfp. The
amplicon was restricted with PstI and NsiI and ligated
with pSB2018 cut with PstI. To create pSB3010 (no attB
sites), pSB2018 was restricted with SmaI/PstI to remove
gfp and then ligated with a SmaI/PstI luxABCDE fragment
excised from pTMP1 (Table 2). The resulting plasmid was
digested with PstI and the PstI/NsiI rrnBT1T2  fragment
inserted downstream of the lux operon (Fig. 3).
Bacterial transformation
E. coli transformation was performed using DB3.1 (for
maintenance of ccdB+ plasmids by virtue of their gyrA462
mutation) or TOP10 (for selection of Entry and Expres-
sion clones) frozen competent cells (Invitrogen). Cells
were plated on LB agar supplemented with Cm (30 µgml-
1), Kanamycin (Km; 30 µgml-1), Ap(50 µgml-1), or Em
(150 µgml-1) as appropriate for the vector used.
Transformation of L.  monocytogenes  and  S. aureus with
plasmids were carried out by electroporation [25,26]. L.
monocytogenes transformants were plated on BHI agar (Cm
7 µgml-1), S. aureus transformants were selected on LB
agar (0.5% xylose, Cm 5 µgml-1). The one step natural
transformation method was used to transform B. subtilis
[16] and plated on LB agar (Cm 7 µg ml-1). Expression of
lux  and  gfp  reporter genes in individual colonies was
detected using a Nightowl CCD camera system with inte-
grated fluorescence excitation (Berthold Technologies).
Plasmid stability measurements
Bacteria were inoculated into BHI broth, with or without
antibiotic selection for the plasmid vector being used.
After overnight culture at 37°C with aeration, samples
were diluted and viable count determined using duplicate
samples grown on plates with and without appropriate
antibiotics. Plasmid loss was determined both after one
night of culture (15 generations) and after subculture
from this initial flask (23 generations). Plasmid loss was
calculated by subtracting the number of antibiotic resist-
ance colonies from the total number of colonies and
expressing this value as a percentage of the total number
of cells. Results presented are the mean of at least two
experiments.
Growth and gene expression measurements
L. monocytogenes or B. subtilis cultures were grown over-
night in rich broth supplemented with suitable antibiotics
at 37°C with shaking (200 rpm). Samples were centri-
fuged at 16,000 × g  for 2 min at room temperature,
washed twice with sterile phosphate buffered saline (PBS)
before resuspending in an equal volume of PBS. The
washed cell suspension was diluted 1/100 (L. monocy-
togenes) or 1/50 (B. subtilis) into either chemically defined
or rich media supplemented with antibiotics as appropri-
ate.
S. aureus overnight cultures were grown aerobically at
37°C in TMS supplemented with Cm (5 µg ml-1). These
were diluted 1/50 into fresh medium and grown for 4 h at
37°C with or without 0.5% xylose. To measure induction
of PxylA cultures were grown without xylose then 0.5%
xylose was added after 4 h. To measure repression of the
xylR PxylA promoter system, cultures were grown for 4 h
with 0.5% xylose, then cells were harvested and washed
(as above) and transferred into media supplemented with
Cm 5 µgml-1 and 1% glucose (for catabolite repression via
XylR; [11]).
For all reporter gene measurements, replicate samples
(200 µl) were placed into the wells of a 96-clear-bottom
microtiter plate (Porvair) and incubated at 37°C in a
Tecan Genesis Pro microplate reader. Optical density (600
nm), fluorescence (RFU; Excitation wavelength = 485 nm,
Emission wavelength = 535 nm) and light levels (RLU)
readings were taken at regular periods over the course of
the experiment.
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